Evidence map›Paper›PMID 28701177›Full record

ArticleMicrobiome2017

Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls.

Christopher J Stewart, Nicholas D Embleton, Emma C L Marrs, Daniel P Smith, Tatiana Fofanova, Andrew Nelson, Tom Skeath, John D Perry, Joseph F Petrosino, Janet E Berrington and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06893939 (Limited Versus Extended Trophic Feeding), which is not on this map. Cited by 176 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed, 5 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06893939 phase2 / phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

TypeinterventionalSponsorUniversity of WashingtonRan2025 to 2031Enrolled350ConditionsSepsis, Length of Stay, Mortality, Neurodevelopmental DelayArmsLimited Trophic Feeds (1 day of trophic feeds), Extended Trophic Feeds (3 days of trophics)
3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 5 syntheses or guidelines pooled it, 278 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Effects ofCell reports. Medicine · 2021
    Trial
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Christopher J StewartAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, 77030, USA. cs12@bcm.edu.
Nicholas D EmbletonNewcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP.77030, UK.
Emma C L MarrsDepartment of Microbiology, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
Daniel P SmithAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, 77030, USA.
Tatiana FofanovaAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, 77030, USA.
Andrew NelsonFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.
Tom SkeathNewcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP.77030, UK.
John D PerryDepartment of Microbiology, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
Joseph F PetrosinoAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, 77030, USA.
Janet E BerringtonNewcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP.77030, UK.
Stephen P CummingsSchool of Science and Engineering, Teesside University, Middlesbrough, TS1 3BX, UK.
Baylor College of Medicine · USRoyal Victoria Infirmary · GBFreeman Hospital · GBNorthumbria University · GBTeesside University · GB

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

backgroundLate onset sepsis (LOS) in preterm infants is associated with considerable morbidity and mortality. While studies have implicated gut bacteria in the aetiology of the disease, functional analysis and mechanistic insights are generally lacking. We performed temporal bacterial (n = 613) and metabolomic (n = 63) profiling on extensively sampled stool from 7 infants with LOS and 28 matched healthy (no LOS or NEC) controls.

resultsThe bacteria isolated in diagnostic blood culture usually corresponded to the dominant bacterial genera in the gut microbiome. Longitudinal changes were monitored based on preterm gut community types (PGCTs), where control infants had an increased number of PGCTs compared to LOS infants (P = 0.011). PGCT 6, characterised by Bifidobacteria dominance, was only present in control infants. Metabolite profiles differed between LOS and control infants at diagnosis and 7 days later, but not 7 days prior to diagnosis. Bifidobacteria was positively correlated with control metabolites, including raffinose, sucrose, and acetic acid.

conclusionsUsing multi-omic analysis, we show that the gut microbiome is involved in the pathogenesis of LOS. While the causative agent of LOS varies, it is usually abundant in the gut. Bifidobacteria dominance was associated with control infants, and the presence of this organism may directly protect, or act as a marker for protection, against gut epithelial translocation. While the metabolomic data is preliminary, the findings support that gut development and protection in preterm infants is associated with increased in prebiotic oligosaccharides (e.g. raffinose) and the growth of beneficial bacteria (e.g. Bifidobacterium).

Indexed as

Gastrointestinal MicrobiomeMetabolomeAcetic AcidBacterial TranslocationBifidobacteriumFecesGastrointestinal TractHumansInfantInfant, NewbornInfant, PrematureInfant, Premature, DiseasesMetabolomicsNeonatal SepsisRaffinoseSucroseAcetic AcidRaffinoseSucroseGut microbiomeLate onset sepsisMetabolomicsPreterm infant

Identifiers

PMID28701177
PMCPMC5508794
OpenAlexW2734475592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.